What the pharmacokinetics permit and what they cannot tell you
The schedules in circulation, described accurately, with their evidentiary status attached.
Pricing
Page 8 of 25 of this archive, newest first.
Australia caps semaglutide prescribing to 23 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
From the floor in Shenzhen: 22 posters, one theme
Reported from the sessions, and from the two hours afterwards.
From the floor in Chengdu: 16 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Sweden caps exenatide prescribing to 18 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
The shortage years, and what they taught about interruption
A supply interruption is a discontinuation with no notice, no taper and no plan. That is a distinct clinical situation.
Poland declines to reimburse dulaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
South Korea caps tirzepatide prescribing to 24 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Norway declines to reimburse exenatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Every fortnight, every third week, seasonally: an unstudied practice
What the exposure arithmetic says about a fortnightly schedule, and where the arithmetic stops being informative.
Poland caps tirzepatide prescribing to 22 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
From the floor in Xi'an: 15 posters, one theme
Reported from the sessions, and from the two hours afterwards.
The lowest effective dose is a real concept with almost no data behind it
What the labels permit, what clinicians do, and the size of the gap between them.
From the floor in Chengdu: 22 posters, one theme
Reported from the sessions, and from the two hours afterwards.